Journal articles on the topic 'Oncolytic viru'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Oncolytic viru.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Shin, Dong Ho, Teresa Nguyen, Bulent Ozpolat, Frederick Lang, Marta Alonso, Candelaria Gomez-Manzano, and Juan Fueyo. "Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy." Journal for ImmunoTherapy of Cancer 9, no. 4 (April 2021): e002086. http://dx.doi.org/10.1136/jitc-2020-002086.
Full textRaimondi, Giulia, Sabrina Gea-Sorlí, Marc Otero-Mateo, and Cristina Fillat. "Inhibition of miR-222 by Oncolytic Adenovirus-Encoded miRNA Sponges Promotes Viral Oncolysis and Elicits Antitumor Effects in Pancreatic Cancer Models." Cancers 13, no. 13 (June 28, 2021): 3233. http://dx.doi.org/10.3390/cancers13133233.
Full textNguyen, Duong Hoang, Thomas Herrmann, Barbara Härtl, Dobrin Draganov, Ivelina Minev, Forrest Neuharth, Alberto Gomez, et al. "Development of Allogeneic Stem Cell-Based Platform for Delivery and Potentiation of Oncolytic Virotherapy." Cancers 14, no. 24 (December 13, 2022): 6136. http://dx.doi.org/10.3390/cancers14246136.
Full textPetrov, Ivan, Ivaylo Gentschev, Anna Vyalkova, Mohamed I. Elashry, Michele C. Klymiuk, Stefan Arnhold, and Aladar A. Szalay. "Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a “Trojan Horse” in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas." Viruses 12, no. 7 (July 12, 2020): 750. http://dx.doi.org/10.3390/v12070750.
Full textWoo, Yanghee, Susanne G. Warner, Rula Geha, Marianne M. Stanford, Penelope Decarolis, Masmudur M. Rahman, Samuel Singer, Grant McFadden, and Yuman Fong. "The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase." Clinical Medicine Insights: Oncology 15 (January 2021): 117955492199306. http://dx.doi.org/10.1177/1179554921993069.
Full textMartikainen, Miika, and Magnus Essand. "Virus-Based Immunotherapy of Glioblastoma." Cancers 11, no. 2 (February 5, 2019): 186. http://dx.doi.org/10.3390/cancers11020186.
Full textEkeke, Chigozirim N., Kira L. Russell, Kyla Joubert, David L. Bartlett, James D. Luketich, Adam C. Soloff, Zong Sheng Guo, Michael T. Lotze, and Rajeev Dhupar. "Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies." Annals of Surgical Oncology 28, no. 5 (February 11, 2021): 2715–27. http://dx.doi.org/10.1245/s10434-020-09477-4.
Full textChavez, Valery A., Floritza Bustamante, Abner Murray, Ashok Saluja, and Jaime Merchan. "Abstract 96: A novel virus-drug combination to enhance oncolysis in colorectal cancer (crc)." Cancer Research 82, no. 12_Supplement (June 15, 2022): 96. http://dx.doi.org/10.1158/1538-7445.am2022-96.
Full textWang, Guan. "Immunodominant and cryptic tumor neoantigen-specific immune responses activated by an armed oncolytic virus expressing a PD-L1 inhibitor." Journal of Immunology 202, no. 1_Supplement (May 1, 2019): 136.5. http://dx.doi.org/10.4049/jimmunol.202.supp.136.5.
Full textSherwood, Matthew, Robert Ewing, Carolini Kaid, Thiago Giove Mitsugi, and Keith Okamoto. "MOMC-1. Employing the Zika Virus to kill paediatric nervous system tumour cells." Neuro-Oncology Advances 3, Supplement_2 (July 1, 2021): ii3. http://dx.doi.org/10.1093/noajnl/vdab070.011.
Full textBryant, Jeffrey, Agnieszka Denslow, Jacqueline Hewett, Lingxin Cong, Ana De Almeida, Jennifer Lee, Judy Jacques, et al. "Abstract 383: ONCR-021 as a systemic intravenous synthetic RNA virus immunotherapy for the repeat treatment of cancer." Cancer Research 82, no. 12_Supplement (June 15, 2022): 383. http://dx.doi.org/10.1158/1538-7445.am2022-383.
Full textTysome, James Russell, Ghassan Alusi, Nick Lemoine, and Yaohe Wang. "Oncolytic Vaccinia Virus Gene Therapy for HNSCC." Otolaryngology–Head and Neck Surgery 139, no. 2_suppl (August 2008): P92—P93. http://dx.doi.org/10.1016/j.otohns.2008.05.500.
Full textBots, Selas T. F., and Rob C. Hoeben. "Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?" International Journal of Molecular Sciences 21, no. 14 (July 8, 2020): 4821. http://dx.doi.org/10.3390/ijms21144821.
Full textSchwertner, Barbara, Georg Lindner, Camila Toledo Toledo Stauner, Elisa Klapproth, Clara Magnus, Anette Rohrhofer, Stefanie Gross, et al. "Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In Vivo." Cancers 13, no. 12 (June 19, 2021): 3058. http://dx.doi.org/10.3390/cancers13123058.
Full textPathak, Upasana, Nagesh Malik, and R. B. Pal. "NDV as an Oncolytic Agent - Study in Cancer Cell Lines." Biosciences Biotechnology Research Asia 19, no. 2 (June 30, 2022): 413–21. http://dx.doi.org/10.13005/bbra/2996.
Full textTumilasci, Vanessa Fonseca, Stephanie Olière, Thi Lien-Ahn Nguyên, April Shamy, John Bell, and John Hiscott. "Targeting the Apoptotic Pathway with BCL-2 Inhibitors Sensitizes Primary Chronic Lymphocytic Leukemia Cells to Vesicular Stomatitis Virus-Induced Oncolysis." Journal of Virology 82, no. 17 (June 25, 2008): 8487–99. http://dx.doi.org/10.1128/jvi.00851-08.
Full textYaacov, Barak, Itay Lazar, Shay Tayeb, Sivan Frank, Uzi Izhar, Michal Lotem, Riki Perlman, Dina Ben-Yehuda, Zichria Zakay-Rones, and Amos Panet. "Extracellular matrix constituents interfere with Newcastle disease virus spread in solid tissue and diminish its potential oncolytic activity." Journal of General Virology 93, no. 8 (August 1, 2012): 1664–72. http://dx.doi.org/10.1099/vir.0.043281-0.
Full textNair, Mitra, Maninder Khosla, Yoshihiro Otani, Margaret Yeh, Flora Park, Toshihiko Shimizu, Jin Muk Kang, et al. "Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation." Cancers 12, no. 4 (April 23, 2020): 1040. http://dx.doi.org/10.3390/cancers12041040.
Full textMuharemagic, D., A. S. Zamay, S. M. Ghobadloo, J. C. Bell, and M. V. Berezovski. "APTAMER-FACILITATED PROTECTION OF ONCOLYTIC VIRUS FROM NEUTRALIZING ANTIBODIES." Siberian Medical Review, no. 5 (2016): 116. http://dx.doi.org/10.20333/25000136-2016-5-116-2.
Full textNettelbeck, Dirk M., Mathias F. Leber, Jennifer Altomonte, Assia Angelova, Julia Beil, Susanne Berchtold, Maike Delic, et al. "Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies." Viruses 13, no. 8 (July 21, 2021): 1420. http://dx.doi.org/10.3390/v13081420.
Full textKimball, Kristopher J., Angel A. Rivera, Kurt R. Zinn, Mert Icyuz, Vaibhav Saini, Jing Li, Zeng B. Zhu, et al. "Novel Infectivity-Enhanced Oncolytic Adenovirus with a Capsid-Incorporated Dual-Imaging Moiety for Monitoring Virotherapy in Ovarian Cancer." Molecular Imaging 8, no. 5 (September 1, 2009): 7290.2009.00025. http://dx.doi.org/10.2310/7290.2009.00025.
Full textKomorowski, Marcin, Joanna Tisonczyk, Agnieszka Kolakowska, Ryszard Drozdz, and Danuta Kozbor. "Modulation of the Tumor Microenvironment by CXCR4 Antagonist-Armed Viral Oncotherapy Enhances the Antitumor Efficacy of Dendritic Cell Vaccines against Neuroblastoma in Syngeneic Mice." Viruses 10, no. 9 (August 26, 2018): 455. http://dx.doi.org/10.3390/v10090455.
Full textWestcott, Marlena M., Jingfang Liu, Karishma Rajani, Ralph D'Agostino, Douglas S. Lyles, and Mercedes Porosnicu. "Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis." Journal of Virology 89, no. 15 (May 20, 2015): 7944–54. http://dx.doi.org/10.1128/jvi.00757-15.
Full textPeter, Malin, and Florian Kühnel. "Oncolytic Adenovirus in Cancer Immunotherapy." Cancers 12, no. 11 (November 13, 2020): 3354. http://dx.doi.org/10.3390/cancers12113354.
Full textLazar, Itay, Barak Yaacov, Tamar Shiloach, Elad Eliahoo, Luna Kadouri, Michal Lotem, Riki Perlman, Zichria Zakay-Rones, Amos Panet, and Dina Ben-Yehuda. "The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin." Journal of Virology 84, no. 1 (October 28, 2009): 639–46. http://dx.doi.org/10.1128/jvi.00401-09.
Full textGoenaga, Anne-Laure, I.-Ming Wang, Bryan S. Clay, Susanne Lang, Annabel Wang, Peter Weady, Smitha P. S. Pillai, et al. "Abstract 5617: A novel genetically modified oncolytic vaccinia virus selectively replicates in tumors to activate an inflammatory TME and induce tumor regression." Cancer Research 82, no. 12_Supplement (June 15, 2022): 5617. http://dx.doi.org/10.1158/1538-7445.am2022-5617.
Full textMeng, Gang, Binghua Li, Anxian Chen, Meihong Zheng, Tiancheng Xu, Hailin Zhang, Jie Dong, Junhua Wu, Decai Yu, and Jiwu Wei. "Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma." British Journal of Cancer 122, no. 1 (December 10, 2019): 111–20. http://dx.doi.org/10.1038/s41416-019-0639-7.
Full textSchirrmacher, Volker. "Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus." Biomedicines 10, no. 3 (February 28, 2022): 562. http://dx.doi.org/10.3390/biomedicines10030562.
Full textHo, Chun-Te, Mei-Hsuan Wu, Ming-Jen Chen, Shih-Pei Lin, Yu-Ting Yen, and Shih-Chieh Hung. "Combination of Mesenchymal Stem Cell-Delivered Oncolytic Virus with Prodrug Activation Increases Efficacy and Safety of Colorectal Cancer Therapy." Biomedicines 9, no. 5 (May 13, 2021): 548. http://dx.doi.org/10.3390/biomedicines9050548.
Full textKoch, Jana, Julia Beil, Susanne Berchtold, Dina Mönch, Annika Maaß, Irina Smirnow, Andrea Schenk, et al. "Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model." Viruses 15, no. 2 (January 27, 2023): 363. http://dx.doi.org/10.3390/v15020363.
Full textJing, Yuqi, F. Bustamante Guerrero, and Jaime Merchan. "Abstract 3293: In vitro cellular and molecular effects of oncolytic vaccinia virus in clear and non-clear cell renal cell carcinoma." Cancer Research 82, no. 12_Supplement (June 15, 2022): 3293. http://dx.doi.org/10.1158/1538-7445.am2022-3293.
Full textMorozov, Dmitriy A., Irina V. Kolyadina, Irina V. Poddubnaya, Petr M. Chumakov, Galina V. Ilinskaya, Vagan Yu Bokhian, and Margarita I. Sopova. "The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)." Journal of Modern Oncology 21, no. 1 (March 15, 2019): 31–35. http://dx.doi.org/10.26442/18151434.2019.1.190299.
Full textHo Shin, Dong, Teresa Nguyen, Hong Jiang, Sagar Sohoni, Sumit Gupta, Ashley Ossimetha, Marta M. Alonso, Candelaria Gomez-Manzano, and Juan Fueyo. "EXTH-39. HEXON SWAPPING MITIGATES ANTI-VIRAL IMMUNE RESPONSE DURING BRAIN TUMOR VIROTHERAPY." Neuro-Oncology 22, Supplement_2 (November 2020): ii95. http://dx.doi.org/10.1093/neuonc/noaa215.393.
Full textClarkson, Matthew F., Aru Narendran, and Randal N. Johnston. "Preclinical Evaluation of Oncolytic Reovirus in Targeted Therapeutics for High-Risk Pediatric Leukemia." Blood 120, no. 21 (November 16, 2012): 3571. http://dx.doi.org/10.1182/blood.v120.21.3571.3571.
Full textLee, Namhee, Yun-Hui Jeon, Jiyoon Yoo, Suk-kyung Shin, Songyi Lee, Mi-Ju Park, Byung-Jin Jung, Yun-Kyoung Hong, Dong-Sup Lee, and Keunhee Oh. "Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies." Journal for ImmunoTherapy of Cancer 11, no. 1 (January 2023): e006024. http://dx.doi.org/10.1136/jitc-2022-006024.
Full textGarcía-Romero, Noemi, Irina Palacín-Aliana, Susana Esteban-Rubio, Rodrigo Madurga, Sergio Rius-Rocabert, Josefa Carrión-Navarro, Jesús Presa, et al. "Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion." Cells 9, no. 6 (June 5, 2020): 1405. http://dx.doi.org/10.3390/cells9061405.
Full textChumakov, P. M. "Could oncolytic viruses provide a breakthrough in oncology?" Вестник Российской академии наук 89, no. 5 (May 6, 2019): 475–84. http://dx.doi.org/10.31857/s0869-5873895475-484.
Full textSong, Xiaotong, Feng Yu, Stephen Gottschalk, and David Bartlett. "Arming oncolytic vaccinia virus with T cell engager to improve virus therapy (P4413)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 205.16. http://dx.doi.org/10.4049/jimmunol.190.supp.205.16.
Full textPhillips, Lynette, Joy Gumin, Shoudong Li, Marc Daou, Daniel Ledbetter, Anwar Hossain, Brittany Parker Kerrigan, Candelaria Gomez-Manzano, Juan Fueyo, and Frederick Lang. "TMOD-16. A NOVEL ADENOVIRAL-PERMISSIVE, IMMUNOCOMPETENT HAMSTER GLIOMA MODEL TO EVALUATE ONCOLYTIC ADENOVIRAL THERAPY." Neuro-Oncology 22, Supplement_2 (November 2020): ii231. http://dx.doi.org/10.1093/neuonc/noaa215.967.
Full textKolodkin-Gal, Dror, Gideon Zamir, Yair Edden, Eli Pikarsky, Alon Pikarsky, Hillel Haim, Yosef S. Haviv, and Amos Panet. "Herpes Simplex Virus Type 1 Preferentially Targets Human Colon Carcinoma: Role of Extracellular Matrix." Journal of Virology 82, no. 2 (October 31, 2007): 999–1010. http://dx.doi.org/10.1128/jvi.01769-07.
Full textMahasa, Khaphetsi Joseph, Rachid Ouifki, Amina Eladdadi, and Lisette de Pillis. "A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept." Mathematical Biosciences and Engineering 19, no. 5 (2022): 4429–57. http://dx.doi.org/10.3934/mbe.2022205.
Full textWilson, Marnie Goodwin, Thi Lien-Anh Nguyen, Laura Shulak, Peyman Nakhaei, and John Hiscott. "Epigenetic modifiers enhance vesicular Stomatitis virus-mediated oncolysis in the refractory PC3 cell line." McGill Science Undergraduate Research Journal 5, no. 1 (March 31, 2010): 61–66. http://dx.doi.org/10.26443/msurj.v5i1.87.
Full textBoisgerault, Nicolas, Jean-Baptiste Guillerme, Daniel Pouliquen, Mariana Mesel-Lemoine, Carole Achard, Chantal Combredet, Jean-François Fonteneau, Frédéric Tangy, and Marc Grégoire. "Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas." BioMed Research International 2013 (2013): 1–11. http://dx.doi.org/10.1155/2013/387362.
Full textNikolaeva, E. Yu, Yu R. Shchetinina, I. E. Shokhin, V. V. Zverev, O. A. Svitich, O. Yu Susova, A. A. Mitrofanov, and Yu I. Ammour. "Measles Virus as a Vector Platform for Glioblastoma Immunotherapy (Review)." Drug development & registration 11, no. 1 (February 23, 2022): 51–58. http://dx.doi.org/10.33380/2305-2066-2022-11-1-51-58.
Full textGuo, Deyin, Fan Xing, Jingshu Xiao, and Jiaming liang. "Abstract LB537: CDK4/6 inhibition enhances oncolytic efficacy on refractory glioblastoma by potentiating tumor-selective cell killing and T cell activation." Cancer Research 82, no. 12_Supplement (June 15, 2022): LB537. http://dx.doi.org/10.1158/1538-7445.am2022-lb537.
Full textSlavin, Shimon, Gila Kazimirsky, Amotz Ziv-Av, and Chaya Brodie. "Role of mesenchymal stem cells in delivering Newcastle disease virus to glioma cells and glioma stem cells and enhancing the oncolytic effect of the virus by secreting TRAIL." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 3100. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.3100.
Full textStavrakaki, Eftychia, Anne Kleijn, Wouter B. van den Bossche, Rutger K. Balvers, Lisette B. Vogelezang, Jie Ju, Andrew Stubbs, et al. "Abstract 3560: Towards personalized oncolytic virotherapy: Differential response of four oncolytic viruses in primary glioblastoma cultures." Cancer Research 82, no. 12_Supplement (June 15, 2022): 3560. http://dx.doi.org/10.1158/1538-7445.am2022-3560.
Full textMarchica, Valentina, Federica Costa, Gaetano Donofrio, and Nicola Giuliani. "Oncolytic Virotherapy and Microenvironment in Multiple Myeloma." International Journal of Molecular Sciences 22, no. 5 (February 24, 2021): 2259. http://dx.doi.org/10.3390/ijms22052259.
Full textScheubeck, Gabriel, Susanne Berchtold, Irina Smirnow, Andrea Schenk, Julia Beil, and Ulrich M. Lauer. "Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus." Viruses 11, no. 7 (July 5, 2019): 614. http://dx.doi.org/10.3390/v11070614.
Full textKim, Goo-Young, Ji Yeon Son, So Jin Lee, Sang Woo Jo, Changhoon In, Sang Hoon Kim, Joon Young Park, et al. "592 Enhancing the therapeutic potential of oncolytic adenoviruses with vSENS™ technology." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A627. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0592.
Full text